TELA Bio Revenue and Competitors

Location

#3383

Growjo Ranking

Estimated Revenue & Valuation

  • TELA Bio's estimated annual revenue is currently $40.2M per year.(i)
  • TELA Bio's estimated revenue per employee is $156,265
  • TELA Bio's total funding is $105M.

Employee Data

  • TELA Bio has 257 Employees.(i)
  • TELA Bio grew their employee count by 25% last year.

TELA Bio's People

NameTitleEmail/Phone
1
Co-Founder, President And CEOReveal Email/Phone
2
CTOReveal Email/Phone
3
COO & CFOReveal Email/Phone
4
Chief Accounting Officer and ControllerReveal Email/Phone
5
VP at TELA BioReveal Email/Phone
6
VP, Engagement & EducationReveal Email/Phone
7
VP - Commercial OperationsReveal Email/Phone
8
VP - IT & ComplianceReveal Email/Phone
9
VP SalesReveal Email/Phone
10
VP MarketingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$73.5M29312%N/AN/A
#2
$7M28-10%N/AN/A
#3
$37.9M15113%N/AN/A
#4
$2.1M17-78%$64.3MN/A
#5
$9.3M37-10%N/AN/A
#6
$56.2M1790%N/AN/A
#7
$38.9M155-1%N/AN/A
#8
$22.1M885%N/AN/A
#9
$22.1M889%N/AN/A
#10
$33.4M13310%N/AN/A
Add Company

What Is TELA Bio?

TELA Bio, a surgical reconstruction company, was created out of the desire to do things differently. Our founders and seasoned leadership team bring their significant experience in medical technology to reinvigorate the soft tissue reconstruction market. Their goal is to build a customer-centric, low-bureaucracy, innovation-oriented organization. TELA Bio has the character of a start-up, with a refreshing approach to the market and a unique portfolio of products. Yet in our effort to create something new, we remain focused on high-quality, data-supported science, and thoughtful decision-making. Surgeons frequently have to work around the problematic features of products currently on the market. At TELA Bio, our starting point is the need for a product that gets it right, and this drives our innovation

keywords:N/A

$105M

Total Funding

257

Number of Employees

$40.2M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TELA Bio News

2022-04-17 - TELA Bio, Inc. (NASDAQ:TELA) Insider Buys $49000.00 in Stock

TELA Bio, Inc, a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical...

2022-04-17 - TELA Bio Appoints D. Taylor Ocasio as General Counsel

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize...

2022-04-13 - TELA Bio, Inc. (NASDAQ:TELA) Sees Large Growth in Short ...

TELA Bio, Inc, a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address...

2021-09-03 - Recent Developments in Soft Tissue Reconstruction to be Explored on an Upcoming Episode of Advancements

JUPITER, Fla. (PRWEB) September 03, 2021 Scheduled to broadcast 4Q/2021, Advancements with Ted Danson will focus on breakthroughs in soft tissue repair solutions. Check local listings for more information. Hearing from experts in the field, viewers will learn about TELA Bio® – a Pennsylvania-b ...

2018-12-11 - Tela Bio raises more than $2 million

Regenerative surgical implants company Tela Bio has brought in more than $2 million in investments, according to a recent U.S. Securities and Exchange Commission filing. The Malvern, Pa.–based company had sought to raise a total $3 million, according to the SEC Form D filed Dec. 4. Get the ful ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1180M25715%N/A
#2
$53.5M26620%N/A
#3
$51.3M2684%N/A
#4
$81.1M273-1%N/A
#5
$88.8M2834%$313.4M